Trials / Sponsors / Amsterdam Molecular Therapeutics
Amsterdam Molecular Therapeutics
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Duration of Effect of Alipogene Tiparvovec Treatment, Which Was Administered in Other Studies Hyperlipoproteinemia Type I | — | 2011-09-01 |
| Unknown | Study to Re-assess and Re-confirm Data Previously Recorded About the Incidence and Severity of Acute Abdominal Lipoprotein Lipase Deficiency | — | 2010-11-01 |
| Completed | Efficacy and Safety of Human Lipoprotein Lipase (LPL)[S447X] Expressed by an Adeno-Associated Viral Vector in Familial Lipoprotein Lipase Deficiency | Phase 2 / Phase 3 | 2009-02-01 |
| Unknown | Safety and Efficacy in LPL-Deficient Subjects of AMT-011, an Adeno-Associated Viral Vector Expressing Human Li Familial Lipoprotein Lipase Deficiency | Phase 2 / Phase 3 | 2007-08-01 |